Aurinia Pharmaceuticals, Inc. (AUPH)
14.02
-0.05
(-0.36%)
USD |
NASDAQ |
Mar 20, 16:00
14.04
+0.02
(+0.11%)
After-Hours: 20:00
Aurinia Pharmaceuticals Research and Development Expense (Quarterly) : 10.90M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 87.09M |
| Oncolytics Biotech, Inc. | 5.457M |
| Edesa Biotech, Inc. | 1.125M |
| Lexaria Bioscience Corp. | 0.6713M |
| ProMIS Neurosciences, Inc. | 9.797M |